We are live on ! Find out more
FIS

FCPM III Services Portfolio holdings

AUM $722M
1-Year Est. Return 73.61%
This Fund
S&P 500
This Quarter Est. Return
+14.54%
1 Year Est. Return
+73.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$592M
AUM Growth
+$10.1M
Cap. Flow
+$10.1M
Cap. Flow %
1.71%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
2
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
ATXS
Astria Therapeutics
ATXS
+$30.5M
2
BCYC
Bicycle Therapeutics
BCYC
+$23.8M
3
ENGN icon
enGene Therapeutics
ENGN
+$7.41M

Top Sells

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$26.2M
2
DYN icon
Dyne Therapeutics
DYN
+$14.5M
3
REPL icon
Replimune Group
REPL
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 99.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$3.47B
$272M 45.98%
10,597,181
-1,234,280
-10% -$26.2M
DYN icon
2
Dyne Therapeutics
DYN
$3.88B
$129M 21.73%
5,462,846
-491,223
-8% -$14.5M
ENGN icon
3
enGene Therapeutics
ENGN
$125M
$64.1M 10.81%
9,632,561
+954,610
+11% +$7.41M
BCYC
4
Bicycle Therapeutics
BCYC
$290M
$48.3M 8.16%
3,452,330
+1,112,369
+48% +$23.8M
REPL icon
5
Replimune Group
REPL
$882M
$48.1M 8.12%
3,970,668
-895,781
-18% -$10.9M
ATXS
6
DELISTED
Astria Therapeutics
ATXS
$25.7M 4.34%
+2,872,537
New +$30.5M
ACHL
7
DELISTED
Achilles Therapeutics
ACHL
$2.75M 0.46%
2,390,050
– –
ENGNW icon
8
enGene Therapeutics Warrants
ENGNW
$3.53M
$2.43M 0.41%
2,878,148
– –

Similar funds

ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
ZAM
Zevin Asset Management Boston, Massachusetts $723M AUM 15.62% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $723M AUM 24.23% 1-Year Est. Return
UW
Unique Wealth Clearwater, Florida $723M AUM 16.35% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
FFM
FengHe Fund Management Singapore $724M AUM 196.18% 1-Year Est. Return
WLIM
White Lighthouse Investment Management Bedford, Massachusetts $721M AUM 16.12% 1-Year Est. Return

FCPM III Services's Q4 2024 Portfolio in Review

As of Q4 2024, FCPM III Services held 8 positions worth $592M, up 1.7% from $582M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

FCPM III Services's Q4 2024 filing shows 1 new, 2 increased and 3 reduced positions. Its largest new stake was Astria Therapeutics: 2,872,537 shares worth $25.7M. The largest sale was NewAmsterdam Pharma, an estimated $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • FCPM III Services's largest Q4 2024 buy was Astria Therapeutics: 2,872,537 shares worth $25.7M.
  • FCPM III Services added most to Bicycle Therapeutics in Q4 2024, an estimated $23.8M increase.
  • FCPM III Services's biggest Q4 2024 reduction was NewAmsterdam Pharma, cutting an estimated $26.2M.
  • FCPM III Services's ten largest holdings make up 100% of its $592M portfolio in Q4 2024.
  • FCPM III Services opened 1 new position and closed 0 in Q4 2024.
  • FCPM III Services's portfolio value rose 1.7% quarter-over-quarter to $592M.

Based on FCPM III Services's 13F filing for Q4 2024, filed 14 Feb 2025.